Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase

A Nationwide Inpatient Database Survey

Naseem, Khadija MD
Sohail, Abdullah MD
Quang Nguyen, Vu MD
Khan, Ahmad MD
Cooper, Gregory MD
Lashner, Bret MD
Katz, Jeffry MD
Cominelli, Fabio MD
Regueiro, Miguel MD
Mansoor, Emad MD

Cleveland Clinic Foundation, Cleveland, OH, USA
The University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Case Western Reserve University, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA
Cleveland Clinic Foundation, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA
Cleveland Clinic Foundation, Cleveland, OH, USA
Case Western Reserve University, Cleveland, OH, USA

Address Correspondence to: Khadija Naseem, MD, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA ([email protected], [email protected]).

Received May 01, 2023

Online date: September 19, 2023

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Inflammatory Bowel Diseases 30(8):p 1334-1344, August 01, 2024. | DOI: 10.1093/ibd/izad200

Lay Summary

This study used nationwide data to examine hospital-related outcomes in patients with inflammatory bowel disease (IBD) and COVID-19 disease. Patients with IBD and COVID-19 had higher mortality, septic shock, mechanical ventilation, and intensive care utilization rates. They also experienced higher costs and longer hospital stays, highlighting the need for preventive measures and timely treatment to improve outcomes and reduce healthcare burden.